Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1988 Dec;50(6):864-71.
doi: 10.1016/s0015-0282(16)60363-1.

Danazol but not gonadotropin-releasing hormone agonists suppresses autoantibodies in endometriosis

Affiliations
Free article
Clinical Trial

Danazol but not gonadotropin-releasing hormone agonists suppresses autoantibodies in endometriosis

A el-Roeiy et al. Fertil Steril. 1988 Dec.
Free article

Abstract

The effect of treatment with danazol (n = 10) or gonadotropin-releasing hormone agonists (GnRH-a) (n = 10) on autoantibody (AA) production (IgG, IgM and, IgA to 6 phospholipids, 5 histones, and 4 polynucleotides) in endometriosis was evaluated blindly in a longitudinal, prospective, randomized study. Clinical improvement, ovarian suppression, and resolution of endometriosis were comparable in both groups. Approximately 50% of patients had significant AA abnormalities initially. During treatment with danazol but not GnRH-a, AA gradually decreased in concentration and in number/patient. Total immunoglobulin levels (IgG, IgM, and IgA) also decreased only in the danazol group. This study indicates that danazol, but not GnRH-a, lowers abnormal AA associated with endometriosis.

PubMed Disclaimer

Comment in

  • Endometriosis and autoantibodies.
    Redwine DB. Redwine DB. Fertil Steril. 1989 Jun;51(6):1068-9. doi: 10.1016/s0015-0282(16)60753-7. Fertil Steril. 1989. PMID: 2656308 No abstract available.

Publication types

LinkOut - more resources